Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pediatric and Adolescent Gynecology, Bethesda, MD, United States.
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pediatric and Adolescent Gynecology, Bethesda, MD, United States.
Contraception. 2022 Jun;110:42-47. doi: 10.1016/j.contraception.2022.01.009. Epub 2022 Jan 24.
The purpose of this study is to use an intersectional approach in which race, insurance, care setting, and disclosure of sexual orientation to a provider are used to assess patterns of contraceptive use in sexual minority women.
This study analyzes cross-sectional data from the 2011-2019 National Survey of Family Growth (NSFG). Sexual orientation of 21,075 respondents' data was used to investigate contraceptive use in sexual minority women, specifically lesbian and bisexual women, as compared to heterosexual women, controlling for variables such as race, age, and socioeconomic factors.
Black and Hispanic lesbian women (adjusted odds ratio [aOR] = 0.39 confidence interval [CI] 0.20-0.76 and aOR = 0.44 CI 0.23-0.82, respectively) and Hispanic and Other Race bisexual women use hormonal contraceptive methods less than their White lesbian and bisexual peers (aOR = 0.45 CI 0.29-0.69 and aOR = 0.43 CI 0.20-0.94). Care setting was not correlated with long-acting reversible contraceptive methods (LARC; such as intra-uterine device, hormonal implants) or prescription-based hormonal methods (such as oral contraceptive pills, injectables, vaginal rings, and patches) in lesbian women (aOR = 2.92 CI 0.60-14.2 and aOR = 1.43 CI 0.47-4.38, respectively) or bisexual women (aOR = 0.90 CI 0.48-1.58 and aOR = 0.83 CI 0.37-1.86), but it was for straight women (aOR = 1.28 CI 1.03-1.59 and aOR = 0.68 CI 0.53-0.86). Similarly, insurance status did not correlate with contraceptive patterns in sexual minority women. Importantly, adjusting for nationally representative data did not impact the results; in other words, the odds ratios after adjusting yielded the same results as before adjustment.
Insurance and care setting are important determinants of straight women's contraceptive use patterns with fewer effects seen among sexual minority women. These findings support previous work and indicate that known advantages of insurance coverage or use of public clinics may not positively impact sexual minority women as much as they do straight women. Provider awareness of sexual identity and sexual orientation is important for adequate contraceptive care.
While prior research has presented findings on sexual minority women contraceptive use, to our knowledge there are limited studies that address the social and demographic implications for contraceptive use in this population.
本研究采用交叉方法,利用种族、保险、护理环境以及向提供者披露性取向等因素,评估性少数群体女性的避孕使用模式。
本研究分析了 2011 年至 2019 年全国家庭增长调查(NSFG)的横断面数据。利用 21075 名受访者的数据来调查性少数群体女性(特别是女同性恋和双性恋女性)的避孕使用情况,并与异性恋女性进行比较,同时控制了种族、年龄和社会经济因素等变量。
黑人和西班牙裔女同性恋者(调整后的优势比[aOR]为 0.39,置信区间[CI]为 0.20-0.76 和 aOR 为 0.44,CI 为 0.23-0.82)和西班牙裔和其他种族的双性恋女性使用激素避孕方法的比例低于其白人女同性恋和双性恋同伴(aOR 为 0.45,CI 为 0.29-0.69 和 aOR 为 0.43,CI 为 0.20-0.94)。护理环境与长效可逆避孕方法(LARC;如宫内节育器、激素植入物)或基于处方的激素方法(如口服避孕药、注射剂、阴道环和贴片)在女同性恋者(aOR 为 2.92,CI 为 0.60-14.2 和 aOR 为 1.43,CI 为 0.47-4.38)或双性恋女性(aOR 为 0.90,CI 为 0.48-1.58 和 aOR 为 0.83,CI 为 0.37-1.86)中均无相关性,但与异性恋女性相关(aOR 为 1.28,CI 为 1.03-1.59 和 aOR 为 0.68,CI 为 0.53-0.86)。同样,保险状况与性少数群体女性的避孕模式也没有相关性。重要的是,对全国代表性数据进行调整并没有影响结果;换句话说,调整后的优势比与调整前的结果相同。
保险和护理环境是影响异性恋女性避孕使用模式的重要决定因素,而对性少数群体女性的影响较小。这些发现支持了之前的研究,并表明保险覆盖或使用公共诊所的已知优势对性少数群体女性的影响并不像对异性恋女性那么大。提供者对性身份和性取向的认识对于充分的避孕护理很重要。
虽然之前的研究已经提出了性少数群体女性避孕使用的研究结果,但据我们所知,针对该人群避孕使用的社会和人口统计学影响的研究有限。